Compare Immunovant Inc. Common Stock (IMVT) vs Iris Energy Limited (IREN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Iris Energy Limited — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Iris Energy Limited trades at $36.88 (market cap $15.25B). The key difference: Iris Energy Limited is far larger — about 2.3× Immunovant Inc. Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Iris Energy Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Iris Energy Limited for 28 Days on average.
| IMVT | IREN | |
|---|---|---|
Market Cap | $6.62B | $15.25B |
Volume | 1,131,364 | 51,114,233 |
Sector | Health | Technology |
52-Week High | $44.96 | $76.41 |
52-Week Low | $17.03 | $29.31 |
Typical Hold Time | 0 Days | 28 Days |
Enterprise Value | $5.72B | $17.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IREN trades at $38.69, down 6.27% amid bearish technical signals despite strong analyst support with 12 buy ratings and an $81 consensus target. The stock faces fundamental challenges with negative net income margin (-99.38%) and ROE (-23.41%) despite 2025 revenue of $501M. Recent news highlights the company's pivot from Bitcoin mining to AI infrastructure with major contracts including a $9.7B Microsoft deal, though execution risks and capital intensity concerns weigh on sentiment.
The outlook remains bifurcated with Wall Street optimism for long-term AI infrastructure growth potential conflicting with near-term profitability challenges. Key opportunities include the 5GW+ power pipeline and hyperscaler partnerships, while risks center on execution of massive spending plans, competitive pressures, and the sustainability of current valuation multiples given negative earnings trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Iris Energy Limited
Iris Energy is a next-generation data center company that powers Bitcoin mining and AI workloads using 100% renewable energy. It focuses on building sustainable infrastructure for the global digital economy.
Read more on IREN →
